These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8595527)

  • 1. Thromboxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock.
    Jesmok G; Gundel R
    Shock; 1995 Nov; 4(5):379-83. PubMed ID: 8595527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
    Altavilla D; Canale P; Squadrito F; Sardella A; Ammendolia L; Urna G; Ioculano M; Squadrito G; Caputi AP
    Pharmacol Res; 1994; 30(2):137-51. PubMed ID: 7816742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of ONO 3708, a new thromboxane A2 receptor antagonist, during experimental endotoxin shock.
    Taneyama C; Sasao J; Senna S; Kimura M; Kiyono S; Goto H; Arakawa K
    Circ Shock; 1989 May; 28(1):69-77. PubMed ID: 2525079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2-receptor blockade and prostacyclin in porcine Escherichia coli shock.
    Svartholm E; Bergqvist D; Hedner U; Ljungberg J; Haglund U
    Arch Surg; 1989 Jun; 124(6):669-72. PubMed ID: 2471490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary function as related to thromboxane A2 synthesis in experimental septic shock.
    Schützer KM; Lindholm E; Haglund U; Falk A
    Circ Shock; 1988 Sep; 26(1):27-40. PubMed ID: 3056632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thromboxane A2-receptor antagonist on bradykinin-induced bronchoconstriction in asthma.
    Rajakulasingam K; Johnston SL; Ducey J; Ritter W; Howarth PH; Holgate ST
    J Appl Physiol (1985); 1996 Jun; 80(6):1973-7. PubMed ID: 8806903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane synthetase inhibition and thromboxane receptor blockade preserve pulmonary and circulatory function in a porcine burn sepsis model.
    Iglesias G; Zeigler ST; Lentz CW; Traber DL; Herndon DN
    J Am Coll Surg; 1994 Aug; 179(2):187-92. PubMed ID: 8044389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock.
    Lambermont B; Ghuysen A; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; D'Orio V
    Arch Physiol Biochem; 2003 Jul; 111(3):224-31. PubMed ID: 14972744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinjury thromboxane receptor blockade ameliorates acute lung injury.
    Goff CD; Corbin RS; Theiss SD; Frierson HF; Cephas GA; Tribble CG; Kron IL; Young JS
    Ann Thorac Surg; 1997 Sep; 64(3):826-9. PubMed ID: 9307481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
    Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
    Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane as a mediator of pulmonary dysfunction during intravascular complement activation in sheep.
    Gee MH; Perkowski SZ; Tahamont MV; Flynn JT; Wasserman MA
    Am Rev Respir Dis; 1986 Feb; 133(2):269-73. PubMed ID: 3753832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.
    Jesmok G; Lindsey C; Duerr M; Fournel M; Emerson T
    Am J Pathol; 1992 Nov; 141(5):1197-207. PubMed ID: 1443053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock.
    Ball HA; Cook JA; Wise WC; Halushka PV
    Intensive Care Med; 1986; 12(3):116-26. PubMed ID: 3016060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep.
    Armstrong RA; Jones RL; Wilson NH
    Prostaglandins; 1985 May; 29(5):703-13. PubMed ID: 2989977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen peroxide-induced broncho- and vasoconstriction in the isolated perfused and ventilated guinea pig lung.
    Bannenberg G; Kimland M; Ryrfeldt A; Moldeus P
    Pharmacol Toxicol; 1993; 72(4-5):314-20. PubMed ID: 8372054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboxane A2 receptor antagonist in asthma therapy].
    Endo S; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):3045-8. PubMed ID: 8950952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tumor necrosis factor-alpha on microvascular permeability in an isolated, perfused lung.
    Schulman CI; Wright JK; Nwariaku F; Sarosi G; Turnage RH
    Shock; 2002 Jul; 18(1):75-81. PubMed ID: 12095138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.